ReproCELL Inc.

ReproCELL Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY32.1
Market Cap
JPY16.17 B
Shares Outstanding
70.91 M
Public Float
66.71 M

Profile

Address
KDX Shin-Yokohama 381 Building, 9/F
Yokohama Kanagawa 222
Japan
Employees -
Website http://www.reprocell.com
Updated 09/14/2018
ReproCELL Inc. engages in the development of diverse products with an underlying theme that focuses on stem cell technology. It operates through the following business divisions: Induced Pluripotent Stem (iPS)/Embryonic Stem (ES) Cells and Clinical Testing. The Induced Pluripotent Stem (iPS)/Embryonic Stem (ES) Cells division handles the manufacture and sale of research reagents, and the production and evaluation of cells.

Financials

View All
Created with Highcharts 5.0.14ReproCELL Inc.Net Income. Fiscal year is April-March. All values JPY Millions.1341344524521 9611 9619129122 1722 1722014201520162017201805001000150020002500
Created with Highcharts 5.0.14ReproCELL Inc.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.4614615675671 0661 0661 2581 258926926201420152016201720180250500750100012501500

Chikafumi Yokoyama
President & Representative Director
Daisuke Usui
Chief Financial Officer, Director & IR Contact